세계의 심부정맥혈전증(DVT) 시장(2025년)

Deep Vein Thrombosis Global Market Report 2025

US $ 4,490 ￦ 6,183,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,938,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,692,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 심부정맥혈전증(DVT) 시장 규모는 향후 수년간 안정된 성장이 전망되고 있으며, 2029년에 13억 2,000만 달러에 달할 것으로 예측되며, CAGR로 4.6%의 성장이 전망됩니다. 예측 기간의 성장은 노령 인구 증가, 생활습관병 유병률 증가, 예방 의료의 중요성, 혁신적인 치료법, 환자 중심 치료의 중요성 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향은 위험 요인에 대한 인식, 진단의 발전, 치료의 혁신, 공중 보건에 대한 노력, 수술 후 예방 등입니다.

심부정맥혈전증(DVT) 치료에 대한 수요 증가는 향후 수년간 DVT 시장의 성장을 가속할 것으로 예상되며, DVT 치료는 심부정맥혈전증(DVT) 환자의 혈전 형성과 확대를 억제하기 위해 항응고제와 같은 약물을 투여하는 것을 포함합니다. 2023년 2월, 미국 질병예방통제센터(CDC)는 미국에서 연간 약 90만 명이 심부정맥혈전증(DVT)에 걸릴 수 있으며, 매년 6만-10만 명의 미국인이 DVT 또는 폐혈전증으로 사망할 수 있다고 예측했습니다.의 미국인이 DVT 또는 폐색전증으로 사망한다고 보고하고 있습니다. 이에 따라 DVT 치료에 대한 수요 증가가 시장 성장의 주요 촉진요인으로 작용하고 있습니다.

비만 증가는 심부정맥혈전증(DVT) 시장의 성장을 가속합니다. 비만은 과도한 체지방 축적을 특징으로 하는 질환으로 다양한 건강 위험과 합병증을 유발하며, DVT와 폐색전증(PE)을 포함한 정맥혈전색전증(VTE)의 독립적인 중등도 위험요인이기 때문에 DVT 치료는 비만 관리에 중요한 역할을 합니다. 현재, 세계심장연맹은 전 세계에서 약 23억 명의 성인과 어린이가 비만 또는 과체중이라고 발표했습니다. 이러한 비만 추세를 볼 때 2025년까지 비만 환자는 27억 명에 달할 것으로 예측됩니다. 따라서 비만의 확산은 심부정맥혈전증(DVT) 시장의 성장을 가속하는 요인으로 작용하고 있습니다.

세계의 심부정맥혈전증(DVT) 시장에 대해 조사분석했으며, 시장의 특징, 시장의 동향과 전략, 각 지역의 분석, 경쟁 구도 등의 정보를 제공하고 있습니다.

목차

제1장 개요

제2장 심부정맥혈전증(DVT) 시장의 특징

제3장 심부정맥혈전증(DVT) 시장 동향과 전략

제4장 심부정맥혈전증(DVT) 시장 - 시장에 대한 금리, 인플레이션, 지정학, COVID와 회복의 영향을 포함한 거시경제 시나리오

제5장 세계의 심부정맥혈전증(DVT) 성장 분석, 전략적 분석 프레임워크

• 세계의 심부정맥혈전증(DVT)에 관한 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 용도 산업의 분석
• 세계의 심부정맥혈전증(DVT) 시장의 성장률 분석
• 세계의 심부정맥혈전증(DVT) 시장 규모와 성장 실적(2019-2024년)
• 세계의 심부정맥혈전증(DVT) 시장 규모와 성장 예측(2024-2029년·2034년)
• 세계의 심부정맥혈전증(DVT) 전체 시장 규모(TAM)

제6장 심부정맥혈전증(DVT) 시장 세분화

• 세계의 심부정맥혈전증(DVT) 시장 : 약제 클래스별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 항응고제
• 하대정맥 필터
• 기타 약제 클래스
• 세계의 심부정맥혈전증(DVT) 시장 : 치료별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 수술
• 약제
• 기타 치료법
• 세계의 심부정맥혈전증(DVT) 시장 : 투여 방식별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 주사
• 경구
• 기타 작용기서
• 세계의 심부정맥혈전증(DVT) 시장 : 유통 채널별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 심부정맥혈전증(DVT) 시장 : 최종사용자별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 병원
• 홈케어
• 전문 클리닉
• 기타 최종사용자
• 세계의 심부정맥혈전증(DVT) 시장, 항응고제의 서브 세분화 : 유형별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 직접 경구 항응고제(DOAC)
• 비타민 K 길항제
• 저분자 헤파린
• 미분화 헤파린
• 세계의 심부정맥혈전증(DVT) 시장, 하대정맥 필터의 서브 세분화 : 유형별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 회수 가능형 IVC 필터
• 영구 유치형 IVC 필터
• 첨단 IVC 필터 시스템
• 세계의 심부정맥혈전증(DVT) 시장, 기타 약제 클래스의 서브 세분화 : 유형별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 혈전용해제
• 항혈소판제
• 섬유소용해제
• 병용요법

제7장 심부정맥혈전증(DVT) 시장의 지역과 국가 분석

• 세계의 심부정맥혈전증(DVT) 시장 : 지역별, 실적과 예측(2019-2024년·2024-2029년·2034년)
• 세계의 심부정맥혈전증(DVT) 시장 : 국가별, 실적과 예측(2019-2024년·2024-2029년·2034년)

제8장 아시아태평양의 심부정맥혈전증(DVT) 시장

제9장 중국의 심부정맥혈전증(DVT) 시장

제10장 인도의 심부정맥혈전증(DVT) 시장

제11장 일본의 심부정맥혈전증(DVT) 시장

제12장 호주의 심부정맥혈전증(DVT) 시장

제13장 인도네시아의 심부정맥혈전증(DVT) 시장

제14장 한국의 심부정맥혈전증(DVT) 시장

제15장 서유럽의 심부정맥혈전증(DVT) 시장

제16장 영국의 심부정맥혈전증(DVT) 시장

제17장 독일의 심부정맥혈전증(DVT) 시장

제18장 프랑스의 심부정맥혈전증(DVT) 시장

제19장 이탈리아의 심부정맥혈전증(DVT) 시장

제20장 스페인의 심부정맥혈전증(DVT) 시장

제21장 동유럽 심부정맥혈전증(DVT) 시장

제22장 러시아의 심부정맥혈전증(DVT) 시장

제23장 북미의 심부정맥혈전증(DVT) 시장

제24장 미국의 심부정맥혈전증(DVT) 시장

제25장 캐나다의 심부정맥혈전증(DVT) 시장

제26장 남미의 심부정맥혈전증(DVT) 시장

제27장 브라질의 심부정맥혈전증(DVT) 시장

제28장 중동의 심부정맥혈전증(DVT) 시장

제29장 아프리카의 심부정맥혈전증(DVT) 시장

제30장 심부정맥혈전증(DVT) 시장의 경쟁 구도와 기업 개요

• 심부정맥혈전증(DVT) 시장의 경쟁 구도
• 심부정맥혈전증(DVT) 시장의 기업 개요
  • Abbott Laboratories
  • Bristol-Myers Squibb Company
  • Sanofi-Aventis US LLC
  • Daiichi Sankyo Company Limited
  • Aspen Pharmacare Holdings Limited

제31장 심부정맥혈전증(DVT) 시장의 기타 주요 기업과 혁신 기업

• Novartis AG
• Mylan N.V.
• Bayer AG
• Boehringer Ingelheim GmbH
• Medtronic PLC
• Hikma Pharmaceuticals PLC
• Laboratorios Farmaceuticos Rovi S.A.
• Cardinal Health Inc.
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca PLC
• Stryker Corporation
• Cook Medical Incorporated
• Boston Scientific Corporation
• Arjo AB
• DJO Global Inc.

제32장 세계의 심부정맥혈전증(DVT) 시장의 경쟁 벤치마킹과 대시보드

제33장 심부정맥혈전증(DVT) 시장의 주요 합병과 인수

제34장 심부정맥혈전증(DVT) 시장의 최근 발전

제35장 심부정맥혈전증(DVT) 시장의 잠재성 높은 국가, 부문, 전략

• 심부정맥혈전증(DVT) 시장 - 가장 새로운 기회를 제공하는 국가(2029년)
• 심부정맥혈전증(DVT) 시장 - 가장 새로운 기회를 제공하는 부문(2029년)
• 심부정맥혈전증(DVT) 시장 - 성장 전략(2029년)
  • 시장 동향에 기반한 전략
  • 경쟁의 전략

제36장 부록

KSA

영문 목차

영문목차

Deep vein thrombosis (DVT) is a serious medical condition characterized by the formation of blood clots in one or more deep veins within the body. Commonly, this condition manifests with symptoms such as swelling, pain, and tenderness in the affected area, typically the leg.

The primary categories of drugs utilized in the treatment of deep vein thrombosis include anticoagulants, inferior vena cava filters, and other therapeutic options. Anticoagulants, commonly referred to as blood thinners, are medications designed to prevent the formation of blood clots in the blood vessels. Treatment approaches for DVT encompass surgical interventions, pharmaceutical interventions, and other modalities. These treatments may be administered through various routes, including injectable, oral, and other methods. The distribution channels for these medications include hospital pharmacies, retail pharmacies, and online pharmacies. Additionally, the end-users for these drugs span diverse healthcare settings such as hospitals, homecare, specialty clinics, and others.

The deep vein thrombosis market research report is one of a series of new reports from The Business Research Company that provides deep vein thrombosis market statistics, including deep vein thrombosis industry global market size, regional shares, competitors with a deep vein thrombosis market share, detailed deep vein thrombosis market segments, market trends and opportunities, and any further data you may need to thrive in the deep vein thrombosis industry. This deep vein thrombosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deep vein thrombosis market size has grown steadily in recent years. It will grow from$1.06 billion in 2024 to $1.1 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increased vascular medicine specialization, influence of medical guidelines, focus on thrombosis prevention, clinical research development, increased diagnosis awareness

The deep vein thrombosis market size is expected to see steady growth in the next few years. It will grow to $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing aging population, rising incidence of lifestyle diseases, preventive healthcare emphasis, innovative therapies, focus on patient-centric care. Major trends in the forecast period include risk factors awareness, advancements in diagnosis, treatment innovations, public health initiatives, post-surgical prevention.

The escalating demand for deep vein thrombosis (DVT) treatment is anticipated to fuel the expansion of the DVT market in the coming years. DVT treatment involves the administration of drugs, including anticoagulants, to mitigate the formation and enlargement of blood clots in individuals with deep vein thrombosis. The growing number of patients seeking DVT treatment signals an upsurge in the prevalence of deep vein thrombosis, necessitating the development of products for DVT diagnosis, prevention, and treatment. In February 2023, the Centers for Disease Control and Prevention (CDC) reported that an estimated 900,000 people in the United States could be affected annually by deep vein thrombosis, with 60,000 to 100,000 Americans succumbing to DVT or pulmonary embolism each year. Consequently, the rising demand for DVT treatment is a key driver propelling market growth.

The increasing incidence of obesity is poised to drive the growth of the deep vein thrombosis market. Obesity, a medical condition characterized by the accumulation of excess body fat, poses various health risks and complications. DVT treatment assumes a crucial role in managing obesity, given its status as an independent and moderate risk factor for venous thromboembolism (VTE), encompassing DVT and pulmonary embolism (PE). As of March 2023, the World Heart Federation disclosed that approximately 2.3 billion adults and children globally are either obese or overweight. With the prevailing obesity trend, projections indicate that the number of individuals living with obesity will reach 2.7 billion by 2025. Hence, the mounting prevalence of obesity stands as a driving force behind the growth of the deep vein thrombosis market.

The deep vein thrombosis market is witnessing a significant trend towards product innovation, with major industry players actively integrating advanced technologies to introduce novel products and fortify their market positions. A case in point is Penumbra Inc., a renowned US-based developer specializing in groundbreaking therapies. In January 2023, the company unveiled Lightning Flash, a state-of-the-art mechanical thrombectomy system meticulously engineered to tackle venous and pulmonary thrombus challenges. This innovative system showcases Penumbra's proprietary lightning-intelligent aspiration technology alongside cutting-edge dual clot detection algorithms. Specifically designed to swiftly address substantial blood clots, including venous thrombus and pulmonary emboli (PE), Lightning Flash equips physicians with a robust, high-torque catheter optimized for the efficient removal of clot burdens in both pulmonary arteries and the deep venous system. Notably, this system upholds an exemplary safety profile, underscoring its potential as a pivotal advancement in DVT treatment modalities.

Major players in the deep vein thrombosis (DVT) market are actively engaging in strategic partnerships to expedite the diagnosis of DVT and optimize their market profitability. This strategic approach underscores a growing interest in harnessing the capabilities of artificial intelligence (AI) and machine learning to enhance medical diagnostics, particularly in the swift and precise identification of DVT. A notable example occurred in November 2023 when UK-based ultrasound AI company ThinkSono Ltd. collaborated with US-based academic medical center NYU Langone Health. Together, they initiated the first clinical trial for an innovative AI-powered ultrasound software, known as the ThinkSono Guidance System. This technology aims to revolutionize the diagnosis of DVT by leveraging AI to potentially achieve faster, more precise, and cost-effective results compared to traditional techniques. The trial involves the utilization of the ThinkSono Guidance System alongside standard ultrasound scanning in patients with and without DVT. The performance of the two approaches will be rigorously assessed to confirm the accuracy of the ThinkSono system. The trial will also benefit from the participation of medical students from the NYU Grossman School of Medicine, contributing to the practical research curriculum.

In March 2024, Pfizer Inc., a U.S.-based biopharmaceutical company, partnered with Bristol-Myers Squibb (BMS) to provide grant support for ongoing professional education focused on anticoagulation in atrial fibrillation and venous thromboembolism. This collaboration encourages organizations to apply for grants that support independent educational initiatives aimed at enhancing the understanding of oral anticoagulant treatments for patients with atrial fibrillation and venous thromboembolism. Bristol-Myers Squibb is also a U.S.-based pharmaceutical company.

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmaceuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.

North America was the largest region in the deep vein thrombosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the deep vein thrombosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The deep vein thrombosis market includes revenues earned by entities by providing services related to treatment such as blood thinning medication, thrombolytic therapy, interventional radiology therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deep Vein Thrombosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deep vein thrombosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deep vein thrombosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The deep vein thrombosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Anticoagulants; Inferior Vena Cava Filters; Other Drug Class
• 2) By Treatment: Surgery; Drugs; Other Treatments
• 3) By Mode Of Administration: Injectable; Oral; Other Modes Of Action
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End-users
• Subsegments:
• 1) By Anticoagulants: Direct Oral Anticoagulants (DOACs); Vitamin K Antagonists; Low Molecular Weight Heparins; Unfractionated Heparin
• 2) By Inferior Vena Cava Filters: Retrievable IVC Filters; Permanent IVC Filters; Advanced IVC Filter Systems
• 3) By Other Drug Class: Thrombolytics; Antiplatelet Agents; Fibrinolytics; Combination Therapy
• Companies Mentioned: Abbott Laboratories; Bristol-Myers Squibb Company; Sanofi-Aventis U.S. LLC; Daiichi Sankyo Company Limited; Aspen Pharmacare Holdings Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Deep Vein Thrombosis Market Characteristics

3. Deep Vein Thrombosis Market Trends And Strategies

4. Deep Vein Thrombosis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Deep Vein Thrombosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Deep Vein Thrombosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Deep Vein Thrombosis Market Growth Rate Analysis
• 5.4. Global Deep Vein Thrombosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Deep Vein Thrombosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Deep Vein Thrombosis Total Addressable Market (TAM)

6. Deep Vein Thrombosis Market Segmentation

• 6.1. Global Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Inferior Vena Cava Filters
• Other Drug Class
• 6.2. Global Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Drugs
• Other Treatments
• 6.3. Global Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Other Modes Of Action
• 6.4. Global Deep Vein Thrombosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Deep Vein Thrombosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-users
• 6.6. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Anticoagulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Oral Anticoagulants (DOACs)
• Vitamin K Antagonists
• Low Molecular Weight Heparins
• Unfractionated Heparin
• 6.7. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Inferior Vena Cava Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retrievable IVC Filters
• Permanent IVC Filters
• Advanced IVC Filter Systems
• 6.8. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombolytics
• Antiplatelet Agents
• Fibrinolytics
• Combination Therapy

7. Deep Vein Thrombosis Market Regional And Country Analysis

• 7.1. Global Deep Vein Thrombosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Deep Vein Thrombosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deep Vein Thrombosis Market

• 8.1. Asia-Pacific Deep Vein Thrombosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deep Vein Thrombosis Market

• 9.1. China Deep Vein Thrombosis Market Overview
• 9.2. China Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deep Vein Thrombosis Market

• 10.1. India Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deep Vein Thrombosis Market

• 11.1. Japan Deep Vein Thrombosis Market Overview
• 11.2. Japan Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deep Vein Thrombosis Market

• 12.1. Australia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deep Vein Thrombosis Market

• 13.1. Indonesia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deep Vein Thrombosis Market

• 14.1. South Korea Deep Vein Thrombosis Market Overview
• 14.2. South Korea Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deep Vein Thrombosis Market

• 15.1. Western Europe Deep Vein Thrombosis Market Overview
• 15.2. Western Europe Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deep Vein Thrombosis Market

• 16.1. UK Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deep Vein Thrombosis Market

• 17.1. Germany Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deep Vein Thrombosis Market

• 18.1. France Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deep Vein Thrombosis Market

• 19.1. Italy Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deep Vein Thrombosis Market

• 20.1. Spain Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deep Vein Thrombosis Market

• 21.1. Eastern Europe Deep Vein Thrombosis Market Overview
• 21.2. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deep Vein Thrombosis Market

• 22.1. Russia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deep Vein Thrombosis Market

• 23.1. North America Deep Vein Thrombosis Market Overview
• 23.2. North America Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deep Vein Thrombosis Market

• 24.1. USA Deep Vein Thrombosis Market Overview
• 24.2. USA Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deep Vein Thrombosis Market

• 25.1. Canada Deep Vein Thrombosis Market Overview
• 25.2. Canada Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deep Vein Thrombosis Market

• 26.1. South America Deep Vein Thrombosis Market Overview
• 26.2. South America Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deep Vein Thrombosis Market

• 27.1. Brazil Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deep Vein Thrombosis Market

• 28.1. Middle East Deep Vein Thrombosis Market Overview
• 28.2. Middle East Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deep Vein Thrombosis Market

• 29.1. Africa Deep Vein Thrombosis Market Overview
• 29.2. Africa Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deep Vein Thrombosis Market Competitive Landscape And Company Profiles

• 30.1. Deep Vein Thrombosis Market Competitive Landscape
• 30.2. Deep Vein Thrombosis Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi-Aventis U.S. LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Aspen Pharmacare Holdings Limited Overview, Products and Services, Strategy and Financial Analysis

31. Deep Vein Thrombosis Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Mylan N.V.
• 31.3. Bayer AG
• 31.4. Boehringer Ingelheim GmbH
• 31.5. Medtronic PLC
• 31.6. Hikma Pharmaceuticals PLC
• 31.7. Laboratorios Farmaceuticos Rovi S.A.
• 31.8. Cardinal Health Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. AstraZeneca PLC
• 31.11. Stryker Corporation
• 31.12. Cook Medical Incorporated
• 31.13. Boston Scientific Corporation
• 31.14. Arjo AB
• 31.15. DJO Global Inc.

32. Global Deep Vein Thrombosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deep Vein Thrombosis Market

34. Recent Developments In The Deep Vein Thrombosis Market

35. Deep Vein Thrombosis Market High Potential Countries, Segments and Strategies

• 35.1 Deep Vein Thrombosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Deep Vein Thrombosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Deep Vein Thrombosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료